Ocular Delivery of Metformin for Sustained Release and in Vivo Efficacy-Reference-Cited by-同舟云学术

Ocular Delivery of Metformin for Sustained Release and in Vivo Efficacy

Published:2023-09 Issue:9 Volume:112 Page:2494-2505
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Regu Vara Prasada Rao,Behera Dhananjay,Sunkara Sai Prathyusha,Gohel Vinit^ORCID,Tripathy Shyamalendu,Swain Ranjit Prasad^ORCID,Subudhi Bharat Bhusan^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference78 articles.

1. Type 2 diabetes as an inflammatory disease;Donath;Nat Rev Immunol,2011

2. Ocular complications of diabetes mellitus;Sayin;World J Diabetes,2015

3. Inflammation in Glaucoma: from the back to the front of the eye, and beyond;Baudouin;Prog Retin Eye Res,2021

4. Katarakt bei Uveitis

5. The effect of intense, short-term topical dexamethasone disodium phosphate eyedrops on blood glucose level in diabetic patients;Kymionis;Ophthalmologica,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tamarind seed polysaccharide-metformin insert: Higher ocular retention, slow-release, and efficacy against corneal burn;International Journal of Pharmaceutics;2024-06

2. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review;International Journal of Molecular Sciences;2024-05-10

3. Drug Delivery for Ocular Allergy: Current Formulation Design Strategies and Future Perspectives;Current Pharmaceutical Design;2023-09